Serum Malondialdehyde in HIV Seropositive Children

Buhl, 1989, Systemic glutathione deficiency in symptom-free HIV-seropositive individuals, Lancet, iii, 1294, 10.1016/S0140-6736(89)91909-0 Staal, 1992, Intracellular glutathione levels in T cell subsets decrease in HIV infected individuals, AIDS Res. Hum. Retrovir, 8, 305, 10.1089/aid.1992.8.305 Souml;nnerborg, 1988, Increased production of malondialdehyde in patients with HIV infection, Scand. J. Infect. Dis., 20, 287, 10.3109/00365548809032453 Eck, 1991, Metabolic disorder as early consequence of simian immunodeficiency virus infection in rhesus macaques, Lancet, 338, 346, 10.1016/0140-6736(91)90482-5 Navel, 1987, An inducible transcription factor activates expression of human immunodeficiency virus in T cells, Nature, 326, 711, 10.1038/326711a0 Roederer, 1990, Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-l-cysteine, Proc. Natl. Acad. Sci. USA, 87, 4884, 10.1073/pnas.87.12.4884 Suzuki, 1992, α-Lipoic acid is a potent inhibitor of NF-κB activation in human T cells, Biochem. Biophys. Res. Commun., 189, 1709, 10.1016/0006-291X(92)90275-P Arpadi, 1991, HIV testing, J. Pediatr., 119, S8, 10.1016/S0022-3476(05)81446-5 MMWR. Center for Disease Control, Atlanta. September 30; 1994. Richard, 1992, High performance liquid chromatography separation of malondialdehyde thiobarbituric acid adduct in biological materials (plasma and human cell) using a commercially available reagent, J. Chromatogr., 577, 9, 10.1016/0378-4347(92)80593-F Miller, 1993, A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates, Clin. Sci., 84, 407, 10.1042/cs0840407 Müller, 1992, Reactive oxygen intermediates and human immunodeficiency virus (HIV) infection, Free Radical Biol. Med., 13, 651, 10.1016/0891-5849(92)90039-J Schwarz, 1996, Oxidative stress during viral infection: a review, Free Rad. Biol. Med., 21, 641, 10.1016/0891-5849(96)00131-1 Müller, 1990, Reduced oxidative burst responses in monocytes and monocyte-derived macrophages from HIV-infected subjects, Clin. Exp. Immunol., 82, 10, 10.1111/j.1365-2249.1990.tb05396.x Suzuki, 1993, Inhibition of NF-κB activation by vitamin E derivatives, Biochem. Biophys. Res. Commun., 193, 2772, 10.1006/bbrc.1993.1620 Roederer, 1992, N-Acetylcysteine: a new approach to anti-HIV therapy, AIDS Res. Hum. Retrovir., 8, 209, 10.1089/aid.1992.8.209 deQuay, 1992, Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine, AIDS, 6, 815, 10.1097/00002030-199208000-00008 Dröge, 1993, Cysteine and glutathione deficiency in AIDS patients: a rationale for the treatment with N-acetyl-cysteine, Pharmacology, 46, 61, 10.1159/000139029 Smilkstein, 1988, Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose, N. Engl. J. Med., 319, 1557, 10.1056/NEJM198812153192401